| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/05/2008 | WO2008067234A2 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 06/05/2008 | WO2008067199A2 Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders |
| 06/05/2008 | WO2008067158A2 METHOD TO PROMOTE HAIR GROWTH AND/OR DELAY OR TREAT HAIR LOSS BY ADMINISTERING A TGF-β ANTAGONIST OR INHIBITOR |
| 06/05/2008 | WO2008067145A2 Self-assembling peptide amphiphiles |
| 06/05/2008 | WO2008067071A2 Immune system programming through b7-dc |
| 06/05/2008 | WO2008067057A2 Cancer treatment |
| 06/05/2008 | WO2008067019A2 Phospholipase c and method of use |
| 06/05/2008 | WO2008066862A2 Methods of diagnosing and alleviating gadolinium toxicity |
| 06/05/2008 | WO2008066845A2 Treatment of metabolic syndrome with norfluoxetine |
| 06/05/2008 | WO2008066715A2 Method of treatment using aspergillus oryzae protease |
| 06/05/2008 | WO2008066621A2 Reversible platelet inhibition |
| 06/05/2008 | WO2008066494A1 THERAPEUTIC USES OF β-ANTAGONISTS |
| 06/05/2008 | WO2008066444A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 06/05/2008 | WO2008066443A1 Il-33 vaccine for the treatment of inflammatory conditions with a strong th2 component |
| 06/05/2008 | WO2008066403A1 Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method |
| 06/05/2008 | WO2008066322A1 A stable hsa-free and antioxidant-free pharmaceutical composition comprising interferon-beta |
| 06/05/2008 | WO2008066070A1 Dipeptidyl peptidase-iv inhibitor |
| 06/05/2008 | WO2008066057A1 Control of cell proliferation targeted for iqgap3 |
| 06/05/2008 | WO2008066032A1 Lymphangiogenesis inhibitory factor |
| 06/05/2008 | WO2008065673A1 A method for producing n-terminal methioine free polypeptides in microbial host cells |
| 06/05/2008 | WO2008065624A1 Interaction partner of neuronatin protein and uses thereof |
| 06/05/2008 | WO2008065372A2 Modified erythropoietin polypeptides and uses thereof for treatment |
| 06/05/2008 | WO2008065369A2 A bleomycin preparation for use against skin tumours |
| 06/05/2008 | WO2008065247A1 Use of beta-lactamase |
| 06/05/2008 | WO2008065144A2 Galenic formulations of organic compounds |
| 06/05/2008 | WO2008065138A1 Novel insulin crystal and method for preparing the crystal |
| 06/05/2008 | WO2008064910A2 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 06/05/2008 | WO2008064907A1 Polypeptides having modulatory effects on cells |
| 06/05/2008 | WO2008064596A1 Pharmaceutical composition comprising p43 protein for the treatment of gastric adenocarcinoma |
| 06/05/2008 | WO2008064552A1 Use of cholinesterase for manufacturing an anti-tachykinins medicament |
| 06/05/2008 | WO2008064540A1 Compositions comprising adeno-associated virus-mediated anti-angiogenic factor-hgfk1 and uses thereof |
| 06/05/2008 | WO2008064487A1 Method for in situ solidification of blood-polymer compositions for regenerative medicine and cartilage repair applications |
| 06/05/2008 | WO2008064465A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan |
| 06/05/2008 | WO2008064451A1 Poxviridae treatment comprising tap-1 and/or tap-2 as a molecular adjuvant |
| 06/05/2008 | WO2008064440A1 Vaccin against group a beta hemolytic streptococcus and respective process for obtaining thereof |
| 06/05/2008 | WO2008064401A1 Improved peptide composition |
| 06/05/2008 | WO2008039818A3 Modified t cell receptors and related materials and methods |
| 06/05/2008 | WO2008034621A3 Nucleotide phosphorylase for the prophylaxis, treatment or diagnosis of acute lung injury (ali) |
| 06/05/2008 | WO2008031092A3 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 06/05/2008 | WO2008024027A3 Use of 9-oxoacridine-10-acetic acid, its salts and esters for enhancing the efficacy of antiandrogenic treatment |
| 06/05/2008 | WO2008011168A3 Glycosylated peptide antagonists of the bradykinin b1 receptor |
| 06/05/2008 | WO2007128588A3 Glutadon |
| 06/05/2008 | WO2007124461A3 Glp-1 compounds |
| 06/05/2008 | WO2007075899A3 Dual agonist compounds and uses thereof |
| 06/05/2008 | WO2007021807A8 Mcp1 fusions |
| 06/05/2008 | WO2006102417A3 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 06/05/2008 | WO2006078892A3 Use of a novel prostate specific membrane antigen for cancer diagnosis and therapy |
| 06/05/2008 | US20080132978 Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132469 Sh2 domain binding inhibitors |
| 06/05/2008 | US20080132464 Selective induction of apoptosis to treat ocular disease |
| 06/05/2008 | US20080132461 Introducing RNA which targets the mRNA of the gene for degradation into the cell or organism; maintaining the cell or organism, maintaining the cell or organism under conditions under which degradation of the mRNA occurs |
| 06/05/2008 | US20080132454 bioavailable ACE-inhibiting peptides that are absorbed intact; protein hydrolysate; hydrolyzing the casein fraction using a protease, subtilisin; foods, beverages |
| 06/05/2008 | US20080132453 amino acid sequence: One example is Nal-Tyr-cyclo(D-Cys-D-Trp-Lys-D-Cys)-Abu-Nal-NH2; lung cancer, glioma, anorexia, hypothyroidism; various D-amino acid-substituted and constrained amino acid-substituted cyclo somatostatin analogs that function as potent mu opioid receptor antagonists |
| 06/05/2008 | US20080132452 treating a an autoimmune condition; administering polypeptide; Goodpasture Syndrome, multiple sclerosis, systemic lupus erythematosus, cutaneous lupus erythematosus, pemphigus, pemphigoid and lichen planus |
| 06/05/2008 | US20080132451 Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease |
| 06/05/2008 | US20080132450 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 06/05/2008 | US20080132449 decorin can dramatically improve the transduction efficiency of gene delivery systems and recombinant adenoviruses expressing decorin can significantly exhibit the potential to penetrate into tumor tissues and anti-tumor effect |
| 06/05/2008 | US20080132448 Conserved neisserial antigens |
| 06/05/2008 | US20080132447 kit; oligonucleotide; diagnose and treat carnitine deficiency |
| 06/05/2008 | US20080132446 Uses of neuronal pannexins for therapy and diagnosis in mammals |
| 06/05/2008 | US20080132445 increasing milk production; inhibiting tumors; administering Galanin with prolactin; transgenic mammal |
| 06/05/2008 | US20080132444 Ocular Agent Delivery Systems |
| 06/05/2008 | US20080132443 inhibiting smooth muscle cell proliferation and/or migration; smooth muscle relaxation; increasing the contractile rate in heart muscle; promoting wound healing; reducing scar formation; disrupting focal adhesions; regulating actin polymerization; host cell; biomedical device |
| 06/05/2008 | US20080132442 biodegradable drug delivery system; fungal infection; inflammation; injection |
| 06/05/2008 | US20080132441 Methods and compositions for modulating medial-lateral neuronal topographic maps |
| 06/05/2008 | US20080132440 Vitamin D or vitamin C complex with polyglutamic acid; improved stability; food, beverage, cosmetic; esterification |
| 06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
| 06/05/2008 | US20080131943 Polynucleotides for production of farnesyl dibenzodiazepinones |
| 06/05/2008 | US20080131931 Expression vector comprising nucleotide sequences coding protein which binds interleukin-10 related t cell-derived inducible factor (IL-TIF); for use in targeting cell for surgical removal |
| 06/05/2008 | US20080131910 Transcription factor specific immunoglobulin for use in treatment and prevention of cell proliferative, respiratory, kidney and liver disorders |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131871 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators |
| 06/05/2008 | US20080131525 Glutamine as a short chain peptide (e.g. dipeptide), and antioxidant selected from selenium, vitamin C, zinc or vitamin E and beta-carotene; parenterally delivered to a critically ill patient for improving mitochondrial function |
| 06/05/2008 | US20080131521 Methods for Preventing or Treating Bone Disorders |
| 06/05/2008 | US20080131513 Sustained-Release Microspheres and Methods of Making and Using Same |
| 06/05/2008 | US20080131509 Self-reinforcing composite biomatrix; use in tissue repair of myocardial infarct for example; two-component gelation system, and a silk protein such as silk-elastin, silk-collagen, silk-laminin, optionally conjugated to a biopolymer |
| 06/05/2008 | US20080131498 liposome-encapsulated busulphan formulations for parenteral administration are provided, as well as such formulations furthermore comprising glutathione and/or at least one glutathione precursor and a process for manufacture of the preparations. The formulations are stable, have improved biodistribution |
| 06/05/2008 | US20080131497 Formulations of DNase and Methods of Use Thereof |
| 06/05/2008 | US20080131495 method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation. |
| 06/05/2008 | US20080131487 medical or dietary treatments comprising administration of a zymogen such as chymosin or other rennins. Embodiments of the invention are directed to treating infant colic, heartburn, gastro-esophageal reflux (GER), gastro-esophageal reflux disease (GERD), irritable bowel syndrome, and recurrent abdominal |
| 06/05/2008 | US20080131477 Device and method for tissue engineering |
| 06/05/2008 | US20080131474 Promoting cardiac tissue repair while inhibiting or reducing vascular occlusion and/or restenosis |
| 06/05/2008 | US20080131465 Group a Streptococcus Crge Protein |
| 06/05/2008 | US20080131444 Rice yellow mottle virus (RYMV) vector for use tool in generation of reporter molecules for gene expression analysis |
| 06/05/2008 | US20080131437 Using allelic variation in cell adhesion molecule (CD164) as tool in treatment and prevntion of skin, arthritic and gastrointestinal disorders |
| 06/05/2008 | US20080131430 Therapeutic Administration Of The Scrambled Anti-Angiogenic Peptide C16Y |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131425 Biomolecular coating for implants |
| 06/05/2008 | US20080131424 Method of treatment and agents useful for same |
| 06/05/2008 | US20080131420 Methods and compositions for treating mucosal inflammation |
| 06/05/2008 | US20080131419 RNA degrading polypeptides for use in prevention and treatment of arthritis, inflammation, restenosis, nervous system and cell proliferative diseases |
| 06/05/2008 | US20080131418 Using concentration of beta crystallin as diagnostic indicator of eye disorders |
| 06/05/2008 | US20080131417 Microarray-based analysis of rheumatoid arthritis markers |
| 06/05/2008 | US20080131411 Using vector transformation comprising wildtype fkhsf gene as therapeutic in prevention and treatment of skin and kidney disorders |
| 06/05/2008 | US20080131406 Angiotensin I Derivatives |
| 06/05/2008 | US20080131400 Vector system |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131398 Combination therapy for treatment of viral infections |
| 06/05/2008 | US20080131397 Uisng Apolipoprotein H (Apo-H) as modulating agent in prevention and treatment of cell proliferative, eye, reproductive, gastrointestinal and joint disorders |